Drugs / JE-CV
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00735644 | Aug 2008 → May 2009 | Japanese encephalitis, hepatitis A virus infection | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JE-CV | “This trial in 1200 JE-vaccination naïve children (age 12-18 mo) in Thailand and the Philippines aimed to demonstrate consistency of three successive industrial scale...” PMID 22777096 ↗ Jul 2012 |
| Modality | Vaccine | “live attenuated Japanese encephalitis chimeric virus vaccine (JE-CV)” PMID 22777096 ↗ Jul 2012 |
| Route | Subcutaneous | “0.5 mL, Subcutaneous” NCT00735644 ↗ |